Sara Ng on Venous Thromboembolism: An Underestimated Global Challenge
Sara Ng, Hematologist at South Western Sydney Local Health District, reposted from Stefano Barco on LinkedIn:
”Venous Thromboembolism: An Underestimated Global Challenge
Venous thromboembolism, encompassing DVT and PE, remains a leading cause of preventable death and disability worldwide.
Why this matters:
• PE can result in shock, respiratory failure, and death. Survivors often face long-term complications such as post-PE syndrome or chronic pulmonary hypertension.
• DVT carries risks of PE and post-thrombotic syndrome, affecting up to 50% of cases.
The reality:
Despite advances in diagnosis (CTPA, biomarkers) and treatment (DOACs, endovascular therapy), global estimates of VTE burden are lacking.
Many regions remain “data deserts” due to limited access to care, inconsistent coding, and under-reporting.
What needs to change:
- International collaboration to harmonise data and fill gaps
- Focus on vulnerable groups: pregnancy, racial/ethnic minorities, and those with chronic conditions
Bottom line:
VTE kills hundreds of thousands annually, yet remains under-recognised.
Accurate global data is essential to drive prevention strategies and improve outcomes.”
Quoting Stefano Barco‘s post:
”Healthcare practitioners, personnel involved in the care of patients with venous thromboembolism, and patient organizations should join together in the global recognition of and awareness on this severe condition, which causes nearly 100,000 deaths per year and is diagnosed in at least 500,000 people per year (only in Europe).
More on VTE (it also includes info material for patients and practitioners!)
Join here: World Thrombosis Day and International Society on Thrombosis and Haemostasis (ISTH).
Our editorial on the global burden of VTE here.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week